N-(5-Bromopyridin-2-yl)acetamide

被引:1
|
作者
Fun, Hoong-Kun [1 ]
Shahani, Tara [1 ]
Kumar, Rajesha [2 ]
Isloor, Arun M. [2 ]
Shivananda, Kammasandra N. [3 ]
机构
[1] Univ Sains Malaysia, Sch Phys, Xray Crystallog Unit, Usm 11800, Penang, Malaysia
[2] Natl Inst Technol Karnataka, Dept Chem, Mangalore 575025, India
[3] Technion Israel Inst Technol, Schulich Fac Chem, IL-32000 Haifa, Israel
关键词
data-to-parameter ratio = 25.5; mean σ(CC) = 0.003 Å; R factor = 0.031; single-crystal X-ray study; T = 296 K; wR factor = 0.081;
D O I
10.1107/S1600536811027553
中图分类号
O7 [晶体学];
学科分类号
0702 ; 070205 ; 0703 ; 080501 ;
摘要
The asymmetric unit of the title compound, C7H7BrN2O, contains two molecules, in one of which the methyl H atoms are disorderd over two orientations in a 0.57 (3):0.43 (3) ratio. The dihedral angles between the pyridine rings and the acetamide groups are 7.27 (11) and 8.46 (11)degrees. In the crystal, molecules are linked by N-H center dot center dot center dot O and C-H center dot center dot center dot O hydrogen bonds generating bifurcated R-2(1)(5) ring motifs, which in turn lead to [110] chains.
引用
收藏
页码:O2043 / U573
页数:10
相关论文
共 50 条
  • [31] 2-(2-Fluorophenyl)-N-(1,3-thiazol-2-yl)acetamide
    Fun, Hoong-Kun
    Quah, Ching Kheng
    Nayak, Prakash S.
    Narayana, B.
    Sarojini, B. K.
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : 02565 - +
  • [32] 2-(2-Methylphenyl)-N-(1,3-thiazol-2-yl)acetamide
    Narayana, B.
    Nayak, Prakash S.
    Sarojini, Balladka K.
    Jasinski, Jerry P.
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2014, 70 : O716 - +
  • [33] N-(2-Chlorophenylsulfonyl)acetamide
    Shakuntala, K.
    Foro, Sabine
    Gowda, B. Thimme
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : O1097 - U175
  • [34] N-(2-Nitrophenylcarbamothioyl)acetamide
    Shahwar, Durre
    Tahir, M. Nawaz
    Chohan, Muhammad Mansha
    Khan, Muhammad Akmal
    Ahmad, Nadeem
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2012, 68 : O1578 - +
  • [35] In-silico Optimization of Drug Likeliness of N-(furan-2-yl Methyl)-2-(1 H-tetrazol-5-yl) Acetamide
    Dwivedi, P. B.
    Parikh, J. A.
    RESEARCH JOURNAL OF CHEMISTRY AND ENVIRONMENT, 2009, 13 (03): : 24 - 28
  • [36] N-(2-Chlorophenyl)acetamide
    Gowda, B. Thimme
    Svoboda, Ingrid
    Fuess, Hartmut
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2007, 63 : O3267 - U4000
  • [37] N-(2-methylphenyl)acetamide
    Gowda, B. Thimme
    Kozísek, Jozef
    Tokarcik, Miroslav
    Fuess, Hartmut
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2007, 63 : O1977 - O1978
  • [38] N-(2-acetylphenyl)acetamide
    Slater, HL
    Rozynski, H
    Crundwell, G
    Glagovich, NM
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2006, 62 : O1957 - O1958
  • [39] N-(2-Methylphenylsulfonyl)acetamide
    Shakuntala, K.
    Foro, Sabine
    Gowda, B. Thimme
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : O1188 - U996
  • [40] 2-{[5-(Diphenylmethyl)-1,3,4-oxadiazol-2-yl]sulfany1}-N-(pyrazin-2-yl)acetamide
    Nayak, Prakash S.
    Narayana, Badiadka
    Samshuddin, Seranthimata
    Sarojini, Balladka Kunhanna
    MOLBANK, 2013, (02)